心脏骤停后氧饱和度目标与神经功能结局:最佳氧疗目标实用探究试验的二次分析
本研究为PILOT试验的二次分析,纳入339例入组前发生心脏骤停的危重成人机械通气患者,比较较低或中等SpO2目标(88%-96%,221例)与较高SpO2目标(96%-100%,118例)对出院时神经功能良好生存(脑功能分类1或2级)的影响。结果显示,较低或中等目标组50例(22.6%)达到主要结局,较高目标组15例(12.7%),绝对风险差9.9个百分点(95%CI 1.8-18.1;P=0.03)。作者认为,心脏骤停后机械通气患者采用较低或中等SpO2目标与神经功能良好结局发生率较高相关,需随机试验证实。
要点
- 心脏骤停后机械通气患者,较低或中等SpO2目标(88%-96%)组神经功能良好生存率22.6%,较高目标组(96%-100%)为12.7%。
- 绝对风险差为9.9个百分点(95%CI 1.8-18.1;P=0.03),支持较低或中等目标可能更优。
- 该分析为PILOT试验的二次分析,339例心脏骤停患者中58.7%为院内心脏骤停,10.2%初始心律可电击。
- 作者认为,需在心脏骤停人群中开展随机试验比较这些目标以证实上述发现。
适用人群与场景
- 入组前发生心脏骤停且接受机械通气的危重成人,为PILOT试验人群中的亚组。
诊断标准与关键阈值
- 主要结局为出院时神经功能良好生存,定义为脑功能分类(Cerebral Performance Category)1或2级。
处置流程与药物剂量
- PILOT试验将接受机械通气的危重成人随机分配至较低(88%-92%)、中等(92%-96%)或较高(96%-100%)SpO2目标。
- 本亚组分析将较低或中等SpO2目标(88%-96%)合并与较高SpO2目标(96%-100%)进行比较。
研究设计与关键结果
- 研究类型为PILOT试验的二次分析;PILOT试验共2987例患者,其中339例(11.3%)在入组前发生心脏骤停。
- 339例中,221例分配至较低或中等SpO2目标,118例分配至较高SpO2目标。
- 总体中位年龄60岁,女性占43.5%,院内心脏骤停占58.7%,初始可电击心律占10.2%。
- 较低或中等SpO2目标组50例(22.6%)达到主要结局,较高SpO2目标组15例(12.7%)达到主要结局。
- 绝对风险差为9.9个百分点(95%CI 1.8-18.1;P=0.03)。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,心脏骤停后接受机械通气的患者采用较低或中等SpO2目标与神经功能良好结局发生率较高相关。
- 作者认为,需在心脏骤停人群中开展随机试验比较这些目标以证实上述发现。
指南或共识出处
- Pragmatic Investigation of Optimal Oxygen Targets(PILOT)试验
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: More than 600,000 adults in the United States experience an out-of-hospital or in-hospital cardiac arrest each year. Following resuscitation from cardiac arrest, most patients receive mechanical ventilation. The oxygenation target that optimizes neurologic outcomes following cardiac arrest is uncertain.
RESEARCH QUESTION: Following cardiac arrest, does a lower oxygen saturation (Spo2) target improve neurologic outcomes compared with a higher Spo2 target?
STUDY DESIGN AND METHODS: This study was a secondary analysis of patients who experienced a cardiac arrest prior to enrollment in the Pragmatic Investigation of Optimal Oxygen Targets (PILOT) trial. The PILOT trial assigned critically ill adults receiving mechanical ventilation to a lower (88%-92%), intermediate (92%-96%), or higher (96%-100%) Spo2 target. This subgroup analysis compared patients randomized to a lower or intermediate Spo2 target (88-96%) vs a higher Spo2 target (96%-100%) regarding the primary outcome of survival with a favorable neurologic outcome at hospital discharge (Cerebral Performance Category 1 or 2).
RESULTS: Of 2,987 patients in the PILOT trial, 339 (11.3%) experienced a cardiac arrest prior to enrollment: 221 were assigned to a lower or intermediate Spo2 target, and 118 were assigned to a higher Spo2 target. Overall, the median age was 60 years, 43.5% were female, 58.7% experienced an in-hospital cardiac arrest, and 10.2% had an initial shockable rhythm. Survival with a favorable neurologic outcome occurred in 50 patients (22.6%) assigned to a lower or intermediate Spo2 target and 15 (12.7%) patients assigned to a higher Spo2 target (absolute risk difference, 9.9 percentage points; 95% CI, 1.8-18.1; P = .03).
INTERPRETATION: Among patients receiving mechanical ventilation following a cardiac arrest, use of a lower or intermediate Spo2 target was associated with a higher incidence of a favorable neurologic outcome compared with a higher target. A randomized trial comparing these targets in the cardiac arrest population is needed to confirm these findings.
参考来源
- DeMasi SC, Clark AT, Muhs AL, et al. Oxygen Saturation Targets and Neurologic Outcomes Following Cardiac Arrest: A Secondary Analysis of the Pragmatic Investigation of Optimal Oxygen Targets Trial. Chest. 2025. PMID: 40316046. doi:10.1016/j.chest.2025.04.027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。